Cara Therapeutics Inc (CARA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

4 STAMFORD PLAZA STAMFORD, CT 06902

Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs. Cara is developing a novel and proprietary class of product candidates, led by KORSUVA™ (CR845/difelikefalin), a first-in-class KOR agonist that targets the body's peripheral nervous system, as well as certain immune cells. In two Phase 3 trials, KORSUVA injection has demonstrated statistically significant reductions in itch intensity and concomitant improvement in quality of life measures in hemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus (CKD-aP). Oral KORSUVA™ has successfully completed a Phase 2 trial for the treatment of pruritus in patients with CKD and is currently in Phase 2 trials in atopic dermatitis, primary biliary cholangitis and notalgia paresthetica patients with moderate-to-severe pruritus.

Data as of 2021-08-02 08:32:22 -0400
Market Cap599.123 Million Shares Outstanding50.052 Million Avg 30-day Volume376.261 Thousand
P/E Ratio42.69992 Dividend Yield EPS0.288
Price/Sales4.65 Debt to Equity1.09 EBITDA12.365 Million
Price to Book Value2.6 Forward PE-0.41 Enterprise Value427.541 Million
Total Cash171.582 Million Current Debt16.519 Million Gross Profit128.924 Million
BETA0.5867 52-week High/Low29.65 / 11.58 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -30.5488
Data provided by IEX Cloud
View SEC Filings from CARA instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 1 100.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 169 154 9.74% 45 (2.64%) 37 (2.15%) 21.62%
13F shares: 32.361 Million 32.637 Million -0.84% 14.584 Million 14.094 Million 3.47%
% Ownership 64.8824 65.4936 -0.93% 29.2398 28.2836 3.38%
New Positions: 34 23 47.83% 12 1 1100.0%
Increased Positions 46 45 2.22% 15 16 -6.25%
Closed Positions 17 25 -32.0% 4 7 -42.86%
Reduced Positions 51 48 6.25% 15 15 0.0%
Total Calls 2.352 Million 836.72 Thousand 181.11% 1.377 Million 446.402 Thousand 208.44%
Total Puts 939.179 Thousand 323.361 Thousand 190.44% 206 Thousand 38.8 Thousand 430.93%
PUT/CALL Ratio 0.4 0.39 2.56% 0.15 0.09 66.67%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CARA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CARA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

13.5 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BAINS HARRISON M JR

  • Director
31,200 2021-06-03 1

IVES JEFFREY L.

  • Director
44,080 2021-06-03 3

VOGELBAUM MARTIN

  • Director
70,560 2021-06-03 2

POSNER CHRISTOPHER

  • Director
45,296 2021-06-03 2

SHIFF SUSAN PH.D.

  • Director
18,000 2021-06-03 1

GONCALVES JOANA CHIEF MEDICAL OFFICER

  • Officer
43,610 2021-04-21 13

MENZAGHI FREDERIQUE PH.D. CHIEF SCIENTIFIC OFF,SVP-R&D

  • Officer
167,319 2021-03-30 5

CHALMERS DEREK T PRESIDENT & CEO

  • Officer
  • Director
1,105,511 2021-03-30 9

TERRILLION SCOTT SEC'Y; CHIEF COMPLIANCE & G.C.

  • Officer
99,342 2021-03-30 5

REILLY THOMAS CHARLES CHIEF FINANCIAL OFFICER

  • Officer
0 2020-10-01 2

MAKARA RICHARD VP, HEAD OF ACCTING;CONTROLLER

  • Officer
0 2020-02-24 0

MOHINDRU MANI CFO & CHIEF STRATEGY OFFICER

  • Officer
17,441 2019-12-02 0

STAUFFER JOSEPH WILLIAM CHIEF MEDICAL OFFICER

  • Officer
2,000 2018-10-17 0

SCHOELL JOSEF CHIEF FINANCIAL OFFICER

  • Officer
50,000 2017-07-26 0

SLAGEL DEAN

  • Director
1,064,338 2017-06-29 0

RHO VENTURES VI LP

RMV VI, L.L.C.

RHO CAPITAL PARTNERS LLC

LESCHLY MARK

KAIROUZ HABIB

RUCH JOSHUA

  • 10% Owner
3,568,057 2017-03-31 0

LEWIS MICHAEL E CHIEF SCIENTIFIC ADVISOR

  • Officer
0 2017-03-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

IVES JEFFREY L. - Director

2021-06-07 19:25:54 -0400 2021-06-07 S 2,520 $13.05 d 15,380 direct 2.2173 4.8041 -4.2129 8.4996 14 -5.5432 30

VOGELBAUM MARTIN - Director

2021-06-07 19:35:52 -0400 2021-06-07 S 8,640 $13.05 d 20,160 direct 2.2173 4.8041 -4.2129 8.4996 14 -5.5432 30

POSNER CHRISTOPHER - Director

2021-06-07 19:33:07 -0400 2021-06-07 S 2,304 $13.04 d 16,096 direct 2.2173 4.8041 -4.2129 8.4996 14 -5.5432 30

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CARA THERAPEUTICS INC CARA 2021-08-05 22:15:04 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 21:45:03 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 21:15:03 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 20:45:03 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 20:15:04 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 19:45:04 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 19:15:03 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 18:45:03 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 18:15:03 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 17:45:03 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 17:15:03 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 16:45:02 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 16:15:03 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 15:45:03 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 15:15:02 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 14:45:02 UTC -0.17 0.25 550000
CARA THERAPEUTICS INC CARA 2021-08-05 14:15:04 UTC -0.17 0.25 600000
CARA THERAPEUTICS INC CARA 2021-08-05 13:45:04 UTC -0.17 0.25 600000
CARA THERAPEUTICS INC CARA 2021-08-05 13:15:03 UTC -0.17 0.25 600000
CARA THERAPEUTICS INC CARA 2021-08-05 12:45:03 UTC -0.17 0.25 550000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund CARA -258.0 shares, $-3408.18 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund CARA -70.0 shares, $-924.7 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund CARA -326.0 shares, $-4306.46 2020-03-31 N-PORT
Advanced Series Trust- AST Academic Strategies Asset Allocation Portfolio CARA -5300.0 shares, $-115063.0 2021-03-31 N-PORT

Elevate your investments